INITIAL COMBINATION THERAPY WITH ADALIMUMAB PLUS METHOTREXATE LEADS TO BETTER LONG-TERM OUTCOMES THAN WITH EITHER MONOTHERAPY IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: 8-YEAR RESULTS OF AN OPEN-LABEL EXTENSION OF A PHASE 3 TRIAL
Author(s):
Breedveld, F.; Keystone, E.; Heijde, D. van der; Landewe, R.; Smolen, J.S.; Guerette, B.; McIlraith, M.; Kupper, H.; Liu, S.F.; Kavanaugh, A.
